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Background
Natural killer (NK) cells play an important role in antivi-
ral immune responses; they kill HIV-1-infected cells either
by direct lysis or through an antibody-dependent cellular
cytotoxicity (ADCC) mechanism. HIV-1-specific ADCC
were mainly detected using the CEM-NK target cell line.
The aim of our study was to analyze the ADCC activity of
various HIV-1-specific antibodies with an assay involving
primary activated NK cells and autologous infected CD4
T-lymphocytes.
Methods
NK cells were purified from PBMC by magnetic bead
selection. Autologous lymphocytes were stimulated by
PHA for 3 days before being infected with different R5
HIV-1 strains for 3 additional days. NK cells previously
activated with IL-2 or IL-15 were added to infected lym-
phocytes for 4 hours in the presence of different concen-
trations of anti-HIV-1-specific antibodies. The percentages
of HIV-1-infected CD4 T-lymphocytes were measured by
the detection of intracellular viral p24 antigen using flow
cytometry. The immuno-phenotype of NK cells and the
expression of CD107a (marker of NK cell degranulation)
were determined in parallel.
Results
Our results show that in the absence of anti-HIV-1-specific
antibodies, activated NK cells reduce by up to 50% the
number of infected CD4 T-lymphocytes by direct lysis. In
the presence of antibodies, the percentage of HIV-1-
infected CD4 T-lymphocytes was further reduced and the
percentage of NK cell degranulation was increased indi-
cating HIV-1-specific ADCC activity. This activity was
compared to other antibody inhibitory activities i.e. HIV-
1 neutralization and Fcgamma receptors-mediated HIV-1
inhibition. Moreover, a correlation between the HIV-1-
specific ADCC and the immuno-phenotype of NK cells
was analyzed.
Conclusion
These results demonstrate that HIV-1-specific antibodies
can inhibit HIV-1 replication in vitro by different mecha-
nisms, including ADCC. If ADCC participates in HIV-1
protection, antibodies displaying ADCC should be
induced by vaccination together with a stimulation of an
innate NK immune response.
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